Carrier Detection in Ornithine Transcarbamylase Deficiency
Overview
Authors
Affiliations
We have studied six known heterozygotes for ornithine transcarbamylase (McKusick 31125; OTC) deficiency. All had abnormal results when tested by measurement of urine orotic acid after protein loading. Duodenal mucosa OTC assay detected fewer of the known heterozygotes but was a useful supplementary test. Urine orotic acid excretion after protein loading is influenced by age and results from women being tested must be compared with those from controls of appropriate age.
Goldstein E, Cannistraro R, Atwal P, Meschia J Neurohospitalist. 2018; 8(2):82-85.
PMID: 29623158 PMC: 5882010. DOI: 10.1177/1941874417729983.
Grunewald S, Fairbanks L, Genet S, Cranston T, Husing J, Leonard J J Inherit Metab Dis. 2004; 27(2):179-86.
PMID: 15159648 DOI: 10.1023/B:BOLI.0000028727.77454.bd.
Potter M, Hammond J, Sim K, Green A, Wilcken B J Inherit Metab Dis. 2001; 24(1):5-14.
PMID: 11286382 DOI: 10.1023/a:1005682017337.
Ornithine carbamoyl transferase deficiency: a neuropathological study.
Harding B, Leonard J, ERDOHAZI M Eur J Pediatr. 1984; 141(4):215-20.
PMID: 6734670 DOI: 10.1007/BF00572763.
BECROFT D, Barry D, Webster D, Simmonds H J Inherit Metab Dis. 1984; 7(4):157-9.
PMID: 6441862 DOI: 10.1007/BF01805599.